CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission
Crossref DOI link: https://doi.org/10.1038/bcj.2017.52
Published Online: 2017-06-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, L H
Biondo, M
Busfield, S J
Arruda, A
Yang, X
Vairo, G
Minden, M D
Text and Data Mining valid from 2017-06-02
Version of Record valid from 2017-06-02
Article History
Received: 27 February 2017
Accepted: 24 March 2017
First Online: 2 June 2017
Competing interests
: The authors declare no conflict of interest.